Properties
Description
AT7519 trifluoroacetate is an CDK kinase inhibitor that disrupts cell division processes. It targets Cdk1/cyclin B, cdk2/cyclin A, Cdk4/cyclin D1, and CDK5/p35.
Molecular Formula
C18H18Cl2F3N5O4
Targets
Cdk1/cyclin B: 210 nM; cdk2/cyclin A: 47 nM; Cdk4/cyclin D1: 100 nM; CDK5/p35: 13 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
AT7519 trifluoroacetate can be utilized in research on the inhibition of multiple CDKs and its therapeutic potential.